• Most Popular
  • Most Shared

Novo gets U.S. approval for PrandiMet

Tue Jun 24, 2008 3:14am EDT

Stocks

   

COPENHAGEN, June 24 (Reuters) - Denmark's Novo Nordisk (NOVOb.CO) said on Tuesday it had received approval from the U.S. Food and Drug Administration for PrandiMet, a fixed-dose combination of an insulin and an insulin sensitiser for type 2 diabetes.

The world's biggest maker of insulin said in a statement PrandiMet was approved as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes. (Reporting by Kim McLaughlin; editing by Sue Thomas)



More from Reuters

Photo

Time Warner Cable, Fox at impasse; blackout looms

NEW YORK (Reuters) - About 13 million Time Warner Cable Inc subscribers were to lose most Fox programing at midnight on Thursday unless the cable service provider reached a last-minute deal to pay fees to News Corp to broadcast the shows.

» More Top News
A customer is served at a counter inside a foreign exchange store displaying a poster of various banknotes including the Chinese yuan or renminbi (RMB) in Hong Kong November 20, 2009. REUTERS/Bobby Yip
OUTLOOK 2010:

Be careful what you wish for

Pressure on China to loosen its grip on the yuan will continue but the U.S. should tread carefully. Here are five world market issues to watch.  Full Article 

Global Markets
Clients work out on machines at the Bally Total Fitness facility in Arvada, Colorado June 15, 2009. REUTERS/Rick Wilking

Get real with resolutions

We make them and we break them: The secret to keeping them is to avoid the impossible dream.  Full Article 

Lifestyle